Neuome Peptides Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$4.33M
- Investors
-
3
Neuome Peptides General Information
Description
Developer of a peptide-based applied technology designed for clinical diagnostics. The company specializes in using a peptide-based approach to disrupt and democratize the diagnostics industry with affordable devices that provide lab-quality results in a fraction of the time and at a fraction of the cost, enabling clinicians to make rapid, informed decisions for improved patient care and outcomes.
Contact Information
Website
www.neuomepeptides.comCorporate Office
- 71 Ayer Rajah Crescent
- Number 03-04/05
- Singapore, 139951
- Singapore
Corporate Office
- 71 Ayer Rajah Crescent
- Number 03-04/05
- Singapore, 139951
- Singapore
Neuome Peptides Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 09-May-2022 | $4.33M | Completed | Startup |
Neuome Peptides Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Neuome Peptides Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EIGHT NDX VENTURES PTE. LTD. | Corporation | Minority | ||
| Mercatus Capital | Family Office | Minority | ||
| New Keynes Investments | Venture Capital | Minority |
Neuome Peptides FAQs
-
When was Neuome Peptides founded?
Neuome Peptides was founded in 2020.
-
Where is Neuome Peptides headquartered?
Neuome Peptides is headquartered in Singapore, Singapore.
-
What industry is Neuome Peptides in?
Neuome Peptides’s primary industry is Drug Discovery.
-
Is Neuome Peptides a private or public company?
Neuome Peptides is a Private company.
-
What is the current valuation of Neuome Peptides?
The current valuation of Neuome Peptides is .
-
What is Neuome Peptides’s current revenue?
The current revenue for Neuome Peptides is .
-
How much funding has Neuome Peptides raised over time?
Neuome Peptides has raised $4.33M.
-
Who are Neuome Peptides’s investors?
EIGHT NDX VENTURES PTE. LTD., Mercatus Capital, and New Keynes Investments have invested in Neuome Peptides.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process